EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.

about

Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test.Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study

P2860

Q47151343-464CE13A-DA83-4F5C-99CE-78123F91D38F Q59137536-3B43E30C-3076-4F75-B015-651293027921

P2860

EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.

Item

http://www.wikidata.org/entity/Q38373208

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

EGFR Mutation Testing of non-s ...... ort from Northern New Zealand.

@en

type

Item

label

EGFR Mutation Testing of non-s ...... ort from Northern New Zealand.

@en

prefLabel

EGFR Mutation Testing of non-s ...... ort from Northern New Zealand.

@en

P1476

EGFR Mutation Testing of non-s ...... ort from Northern New Zealand.

@en

P2093

Angie Li

http://www.w3.org/2001/XMLSchema#string

Christopher Lewis

http://www.w3.org/2001/XMLSchema#string

Donald Love

http://www.w3.org/2001/XMLSchema#string

George Laking

http://www.w3.org/2001/XMLSchema#string

Karen Sheath

http://www.w3.org/2001/XMLSchema#string

Mark Elwood

http://www.w3.org/2001/XMLSchema#string

Mark McKeage

http://www.w3.org/2001/XMLSchema#string

Nicola Kingston

http://www.w3.org/2001/XMLSchema#string

Phillip Shepherd

http://www.w3.org/2001/XMLSchema#string

Phyu Aye

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Erlotinib in previously treated non-small-cell lung cancer

Screening for epidermal growth factor receptor mutations in lung cancer

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Some Methods for Strengthening the Common χ 2 Tests

P2888

s11523-017-0515-4

P31

scholarly article

P356

10.1007/S11523-017-0515-4

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090603305

http://www.w3.org/2001/XMLSchema#string

P698

28699084

http://www.w3.org/2001/XMLSchema#string

P921

New Zealand

EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.

about

P2860

P2860

EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P921